Prime Medicine unveils program for treatment of AATD
Prime Medicine (PRME) unveiled a preclinical program for the treatment of alpha-1 antitrypsin deficiency, AATD, the next program within its ...
Becker's Hospital Review8h
Inside Prime’s acquisition of 8 Ascension hospitals
Ontario, Calif.-based Prime Healthcare completed its acquisition of eight St. Louis-based Ascension hospitals in Illinois. The hospitals included in the acquisition were Ascension Holy Family in Des ...
Al Jazeera18h
Why are Caribbean leaders fighting Trump to keep Cuban doctors?
Cuban medical missions provide crucial support to several Caribbean healthcare systems, especially in times of crisis.
Israel-Hamas war live updates: More than 400 Palestinians killed in Israeli strikes on Gaza
More than 200 Palestinians were killed in overnight Israeli strikes on the Gaza Strip, the Hamas-ruled enclave's Ministry of ...
Israeli strikes across Gaza kill at least 404 Palestinians and shatter ceasefire with Hamas
Prime Minister Benjamin Netanyahu ordered the strikes after Hamas refused Israeli demands to change the ceasefire agreement.
Prime sets sights on liver, lung disease as next target for its gene editing tech
The biotech unveiled a new research program in alpha-1 antitrypsin deficiency, a disease that’s also a focus for rival Beam Therapeutics.